Best Practice & Research Clinical Anaesthesiology
Volume 22, Issue 1 , Pages 81-94 , March 2008

Antiplatelet therapy and coronary stents in perioperative medicine – the two sides of the coin

  • Helfried Metzler, MD (Chief)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +43 316 385 4663; Fax: +43 316 385 4664.

References 

  1. Thom T, Haase N, Rosamond W, Howard VJ. Heart disease and stroke statistics – 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006;113:e85–e151
  2. Al Suwaidi J, Berger PB, Holmes DR. Coronary artery stents. Journal of the American Medical Association. 2000;284:1828–1836
  3. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. The New England Journal of Medicine. 2007;356:1503–1516
  4. Katritsis DG, Karvouni E, Ioannidis JP. Meta-analysis comparing drug-eluting stents with bare metal stents. American Journal of Cardiology. 2005;95:640–643
  5. Muni MN, Gross TP. Problems with drug-eluting stents – the FDA perspective. The New and Journal of Medicine. 2004;351:1593–1594
  6. Pfisterer M, Brunner-La Rocca HP, Buser PT, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents. Journal of the American College of Cardiology. 2006;48:2584–2591
  7. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. Journal of the American Medical Association. 2005;293:2126–2130
  8. Farb A, Boam AB. Stent thrombosis redux – the FDA perspective. The New England Journal of Medicine. 2007;356:984–987
  9. Maisel WH. Unanswered questions – drug eluting stents and the risk of late thrombosis. The New England Journal of Medicine. 2007;356:981–984
  10. Serruys PW, Kutryk MJB, Ong ATL. Coronary-artery stents. The New England Journal of Medicine. 2006;354:483–495
  11. Kastrati A, Mehilli J, Pache J, Kaiser C. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. The New England Journal of Medicine. 2007;356:1030–1039
  12. Lageerqvist V, James SK, Stenestrand U, Lindbäck J. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. The New England Journal of Medicine. 2007;356:1009–1019
  13. Mauri L, Hsieh W, Massaro JM, Ho KKL. Stent thrombosis in randomized clinical trials of drug-eluting stents. The New England Journal of Medicine. 2007;356:1020–1029
  14. Spaulding C, Daemen J, Boersma E, Cutlip DE. A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. The New England Journal of Medicine. 2007;356:989–997
  15. Stone GW, Moses JW, Ellis SG, Schofer J. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. The New England Journal of Medicine. 2007;356:998–1008
  16. Yusuf S, Zhao F, Mehta SR, Chrolavicius S. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment in elevation. The New England Journal of Medicine. 2001;345:494–502
  17. Mehta SR, Yusuf S, Peters RJG, Bertrand ME. Effects of pre-treatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet. 2001;358:527–533
  18. Silber S, Albertsson P, Avilés FF, Camici PG. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. European Heart Journal. 2005;26:804–847
  19. Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK. ACC/AHA/SCAI 2005 Guideline update for percutaneous coronary intervention – summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Journal of the American College of Cardiology. 2006;47:216–235
  20. Grines CL, Bonow RO, Casey DE, Gardner T. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation. 2007;115:813–818
  21. Vicenzi MN, Ribitsch D, Luha O, Klein W. Coronary artery stenting before noncardiac surgery: more threat than safety?. Anesthesiology. 2001;94:367–368
  22. Kaluza GL, Joseph J, Lee JR, Raizner ME. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. Journal of the American College of Cardiology. 2000;35:1288–1294
  23. Wilson SH, Fasseas P, Orford JL, Lennon RJ. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. Journal of the American College of Cardiology. 2003;42:234–240
  24. McFadden EP, Stabile E, Regar E, Cheneau E. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004;364:1519–1521
  25. Reddy PR, Vaitkus PT. Risks of noncardiac surgery after coronary stenting. American Journal of Cardiology. 2005;95:755–757
  26. Satler LF. Recommendations regarding stent selection in relation to the timing of noncardiac surgery postpercutaneous coronary intervention. Catheterization and Cardiovascular Interventions. 2004;63:146–147
  27. Marcucci C, Chassot PG, Gardaz JP, Magnusson L. Fatal myocardial infarction after lung resection in a patient with prophylactic preoperative coronary stenting. British Journal of Anaesthesia. 2004;92:743–747
  28. Vicenzi MN, Meislitzer T, Heitzinger B, Halaj M. Coronary artery stenting and non-cardiac surgery – a prospective outcome study. British Journal of Anaesthesia. 2006;96:686–693
  29. De Souza DG, Baum VC, Ballert NM. Late thrombosis of a drug-eluting stent presenting in the perioperative period. Anesthesiology. 2007;106:1057–1059
  30. Brilakis ES, Banerjee S, Berger PB. Perioperative management of patients with coronary stents. Journal of the American College of Cardiology. 2007;49:2145–2150
  31. Howard-Alpe G, De Bono J, Hudsmith L, et al. Coronary stents in the non-cardiac perioperative period. British Journal of Anaesthesia. 2007;98:560–574
  32. Ferrari E, Benhamou M, Cerboni P, Marcel B. Coronary syndromes following aspirin withdrawal. Journal of the American College of Cardiology. 2005;45:456–459
  33. Albaladejo P, Marret E, Piriou V, Samama CM. Perioperative management of antiplatelet agents in patients with coronary stents: recommendations of a French Task Force. British Journal of Anaesthesia. 2006;97:580–585
  34. Collet JP, Montalescot G. Premature withdrawal and alternative therapies to dual oral antiplatelet therapy. European Heart Journal. 2006;8:G46–G52
  35. Tanaka KA, Szlam F, Kelly AB, Vega D. Clopidogrel (Plavix®) and cardiac surgical patients: implications for platelet function monitoring and postoperative bleeding. Platelets. 2004;15:325–332
  36. Wang TH, Bhatt DL, Topol EJ. Aspirin and clopidogrel resistance: an emerging clinical entity. European Heart Journal. 2006;27:647–654
  37. Burger W, Chemnitius JM, Kneissl GD, Rücker G. Low-dose aspirin for secondary cardiovascular prevention – cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation – review and meta-analysis. Journal of Internal Medicine. 2005;257:399–414
  38. Auerbach A, Goldmann L. Assessing and reducing the cardiac risk of noncardiac surgery. Circulation. 2006;113:1361–1376
  39. Brilakis ES, Orford JL, Fasseas P, Wilson SH. Outcome of patients undergoing balloon angioplasty in the two month prior to noncardiac surgery. American Journal of Cardiology. 2005;96:512–514
  40. Posner KL, Van Norman GA, Chan V. Adverse cardiac outcomes after noncardiac surgery in patients with prior percutaneous transluminal coronary angioplasty. Anesthesia & Analgesia. 1999;89:553–560
  41. Hongo RH, Ley J, Dick SE, Yee RR. The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting. Journal of the American College of Cardiology. 2002;40:231–237
  42. Chen L, Bracey AW, Radovancevic R, Cooper JR. Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting. Journal of Thoracic and Cardiovascular Surgery. 2004;128:425–431
  43. Chu MWA, Wilson SR, Novick RJ, Stitt LW. Does clopidogrel increase blood loss following coronary artery bypass surgery?. Annals of Thoracic Surgery. 2004;78:1536–1541
  44. Ascione R, Ghosh A, Rogers CA, Cohen A. In-hospital patients exposed to clopidogrel before coronary artery bypass graft surgery: a word of caution. Annals of Thoracic Surgery. 2005;79:1210–1216
  45. Merritt JC, Bhatt DL. The efficacy and safety of perioperative antiplatelet therapy. Journal of Thrombosis and Thrombolysis. 2004;17:21–27
  46. Rodgers RP, Levin J. A critical reappraisal of the bleeding time. Seminars In Thrombosis and Hemostasis. 1990;16:1–20
  47. Luddington RJ. Thrombelastography/thrombelastometry. Clinical and Laboratory Haematology. 2005;27:81–90
  48. Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature. 1962;194:927–929
  49. Matzdorff A. Platelet function tests and flow cytometry to monitor antiplatelet therapy. Seminars In Thrombosis and Hemostasis. 2005;31:393–399
  50. Cardinal DC, Flower RJ. The electronic aggregometer: a novel device for assessing platelet behavior in blood. Journal of Pharmacological Methods. 1980;3(2):135–158
  51. Dyszkiewicz-Korpanty AM, Frenkel EP, Sarode R. Approach to the assessment of platelet function: comparison between optical-based platelet-rich plasma and impedance-based whole blood platelet aggregation methods. Clinical and Applied Thrombosis/Hemostasis. 2005;11:25–35
  52. Bauriedel G, Skowasch D, Schneider M. Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry. American Heart Journal. 2003;145:343–348
  53. Koscielny J, von Tempelhoff GF, Ziemer S. A practical concept for preoperative management of patients with impaired primary hemostasis. Clinical and Applied Thrombosis/Hemostasis. 2004;10:155–166
  54. Agarwal S, Coakely M, Reddy K. Quantifying the effect of antiplatelet therapy: a comparison of the platelet function analyzer (PFA-100®) and modified thrombelastography (mTEG®) with light transmission platelet aggregometry. Anesthesiology. 2006;105:676–683
  55. Hezard N, Metz D, Nazeyrollas P. PFA-100 and flow cytometry: can they challenge aggregometry to assess antiplatelet agents, other than GPIIbIIIa blockers, in coronary angioplasty?. Thrombosis Research. 2002;108:43–47
  56. Horlocker TT, Wedel DJ, Benzon H. Regional anesthesia in anticoagulated patients: defining the risks (the second ASRA Conference of Neuroaxial Anesthesia and Anticoagulation). Regional Anesthesia and Pain Medicine. 2003;28:172–198
  57. Gogarten W, VanAken H, Büttner J. Rückenmarksnahe Regionalanästhesien und Thromboembolieprophylaxe/antithrombotische Medikation. Anästhesiologie and Intensive Medicine. 2003;44:218–230
  58. Kozek-Langenecker S, Fries D, Gütl M, et al. Lokoregionalanästhesien unter gerinnungshemmender Medikation. Empfehlungen der Arbeitsgruppe Perioperative Gerinnung der Österreichischen Gesellschaft für Anästhesiologie und Intensivmedizin. Anaesthesist. 2005;54:476–484
  59. Harding S, Severn A, Calvert J. Aspirin and central neural blockade. Anaesthesia. 2002;57:304–305
  60. Tyagi A, Bhattacharya A. Central neuraxial blocks and anticoagulation: a review of current trends. European Journal of Anaesthesiology. 2002;19:317–329
  61. Lecompte T, Hardy J. Antiplatelet agents and perioperative bleeding. Canadian Journal of Anaesthesia. 2006;53:S103–S112
  62. Rodgers A, Walker N, Schug S. Reduction of postoperative mortality with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ. 2000;321:1493
  63. Herbstreit F, Peters J. Case report. Spinal anaesthesia despite combined Clopidogrel and aspirin therapy in a patient awaiting lung transplantation: effects of platelet transfusion on clotting tests. Anaesthesia. 2005;60:85–87
  64. Mahla E, Lang T, Vicenzi M. Thrombelastography for monitoring prolonged hypercoagulability after major abdominal surgery. Anesthesia & Analgesia. 2001;92:572–577
  65. Scharbert G, Deutsch E, Kress H. Inhibition of platelet function by hydroxyethyl starch solutions in chronic pain patients undergoing peridural anesthesia. Anesthesia & Analgesia. 2004;99:823–827

PII: S1521-6896(07)00084-5

doi: 10.1016/j.bpa.2007.09.004

Best Practice & Research Clinical Anaesthesiology
Volume 22, Issue 1 , Pages 81-94 , March 2008

Article Tools

* Image Usage & Resolution